| # | Title | Journal | Year | Citations |
|---|
| 1 | 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS | Europace | 2016 | 3,523 |
| 2 | 2012 focused update of the ESC Guidelines for the management of atrial fibrillation | Europace | 2012 | 2,319 |
| 3 | 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the E | Europace | 2012 | 1,497 |
| 4 | Guidelines for the management of atrial fibrillation | Europace | 2010 | 1,360 |
| 5 | Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation | Europace | 2015 | 951 |
| 6 | 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) | Europace | 2013 | 908 |
| 7 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation | Europace | 2018 | 767 |
| 8 | HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Soci | Europace | 2007 | 741 |
| 9 | European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation | Europace | 2013 | 721 |
| 10 | HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) | Europace | 2011 | 699 |
| 11 | ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society | Europace | 2006 | 661 |
| 12 | 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | Europace | 2015 | 635 |
| 13 | Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society | Europace | 2015 | 589 |
| 14 | ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart R | Europace | 2006 | 546 |
| 15 | Guidelines on Management (diagnosis and treatment) of syncope ? update 2004 | Europace | 2004 | 542 |
| 16 | Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes | Europace | 2013 | 494 |
| 17 | 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation | Europace | 2021 | 494 |
| 18 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication | Europace | 2016 | 471 |
| 19 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary | Europace | 2018 | 375 |
| 20 | 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy | Europace | 2022 | 370 |
| 21 | New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge | Europace | 2000 | 369 |
| 22 | Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose–response meta-regression | Europace | 2013 | 357 |
| 23 | Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis | Europace | 2015 | 355 |
| 24 | The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management | Europace | 2008 | 352 |
| 25 | Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF) | Europace | 2014 | 349 |
| 26 | EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) | Europace | 2009 | 337 |
| 27 | Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis | Europace | 2009 | 329 |
| 28 | Post-operative atrial fibrillation: a maze of mechanisms | Europace | 2012 | 322 |
| 29 | Indications for the use of diagnostic implantable and external ECG loop recorders | Europace | 2009 | 309 |
| 30 | Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients | Europace | 2013 | 308 |
| 31 | EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation | Europace | 2015 | 302 |
| 32 | 2010 Focused Update of ESC Guidelines on device therapy in heart failure | Europace | 2010 | 297 |
| 33 | Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study | Europace | 2008 | 289 |
| 34 | Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement | Europace | 2013 | 281 |
| 35 | A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry | Europace | 2014 | 280 |
| 36 | Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association | Europace | 2007 | 278 |
| 37 | EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion | Europace | 2014 | 259 |
| 38 | Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association | Europace | 2007 | 254 |
| 39 | Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention | Europace | 2011 | 249 |
| 40 | 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management: A registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society; and in collaboration with the Heart Failure Society of America (HFSA), the American Society of Echocardiography (ASE), the American Heart Association (AHA), the European Association of Echocardiography (EAE) of the ESC and the Heart Failure Association of the ESC (HF | Europace | 2012 | 249 |
| 41 | PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study | Europace | 2018 | 246 |
| 42 | 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope | Europace | 2000 | 245 |
| 43 | 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias | Europace | 2019 | 245 |
| 44 | 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS | Europace | 2018 | 243 |
| 45 | Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures | Europace | 2014 | 242 |
| 46 | EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy | Europace | 2010 | 240 |
| 47 | Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals | Europace | 2008 | 237 |
| 48 | Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction | Europace | 2010 | 237 |
| 49 | Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis | Europace | 2018 | 234 |
| 50 | Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol | Europace | 2018 | 226 |
